Hypoxia promotes tumor cell motility via RhoA and ROCK1 signaling pathways
- 7 January 2014
- journal article
- editorial
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 111 (3) , 887-888
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targetingProceedings of the Japan Academy, Series B, 2012
- High-resolution genome-wide mapping of HIF-binding sites by ChIP-seqBlood, 2011
- Targeting hypoxia in cancer therapyNature Reviews Cancer, 2011
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant MetastasisCancer Cell, 2009
- The impact of O2 availability on human cancerNature Reviews Cancer, 2008
- Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapyInternational Journal of Radiation Biology, 2006
- Heterogeneous Vascular Dependence of Tumor Cell PopulationsThe American Journal of Pathology, 2001
- Oxygenation predicts radiation response and survival in patients with cervix cancerRadiotherapy and Oncology, 1998
- Extracellular matrix-dependent tissue-specific gene expression in mammary epithelial cells requires both physical and biochemical signal transduction.Proceedings of the National Academy of Sciences, 1994
- The Histological Structure of Some Human Lung Cancers and the Possible Implications for RadiotherapyBritish Journal of Cancer, 1955